Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20190602043790N2
IRCT20190602043790N2RecruitingPhase 3

Comparison of Methylphenidate with the Combanition of Methylphenidate (MPH) and Crocus sativus (Saffron) in the treatment of children and adolescents with Attention-Deficit Hyperactivity Disorder (ADHD): a Randomized, Double Blind Clinical Trial

Khoram-Abad University of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
90
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
6 years to 16 years (—)
Sex
All

Inclusion Criteria

  • •Diagnosis of attention-deficit-hyperactivity disorder based on diagnostic and Statistical Manual of Mental Disorders (DSM)
  • •Lack of mental retardation
  • •No use of Methylphenidate and Crocus sativus (saffron) before the study

Exclusion Criteria

  • •Parent's dissatisfaction to participate in study
  • •Psychiatric comorbidities (except for oppositional defiant disorder)
  • •Drug allergy

Investigators

Sponsor
Khoram-Abad University of Medical Sciences

Similar Trials

Completed
Phase 3
Methylphenidate and atomoxetine in attention deficit hyperactivity disorder
IRCT20110802007202N15Tehran University of Medical Sciences36
Completed
Not Applicable
Effects of massage on students with ADHDAttention Deficit/ Hyperactivity Disorders.Disturbance of activity and attention
IRCT201305142531N2Qom University of Medical Sciences30
Completed
Phase 3
Evaluation of the effect of Methylphenidate on consciousness in patients ?with brain damage in ICBrain damage.Unspecified brain damage due to birth injuryP11.2
IRCT20141209020258N128Arak University of Medical Sciences90
Recruiting
Phase 1
Evaluation of the efficacy of Methylphenidate and modafinil in the treatment of excessive daily sleepiness in patients with drug-resistant epilepsy and comparison with the control groupEpilepsy.Epilepsy and recurrent seizures
IRCT20171030037093N22Esfahan University of Medical Sciences84
Recruiting
Phase 3
Evaluation of methylphenidate on level of conciseness and hospital length of stay in patients with severe and moderate acute traumatic brain injury
IRCT20140915019185N3Mazandaran University of Medical Sciences62